Table 3.
Multivariate analysis of DFS and OS for 170 NSCLC patients
| DFS | OS | |||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| P value | HR | 95% CI | P value | HR | 95% CI | |
| Histological differentiation (well, moderate, poor) | 0.031 | 1.434 | 1.033 to 1.992 | 0.017 | 1.520 | 1.077 to 2.145 |
| T stage (T1, T2, T3-4) | 0.909 | 0.981 | 0.702 to 1.370 | 0.290 | 0.833 | 0.594 to 1.168 |
| Lymph node metastasis (no, yes) | <0.001 | 3.261 | 2.044 to 5.204 | <0.001 | 3.035 | 1.910 to 4.823 |
| Vav1 (negative, low, high) | <0.001 | 1.810 | 1.391 to 2.356 | <0.001 | 2.079 | 1.564 to 2.762 |
P Values <0.05 were considered to be significant. DFS, disease-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval.